Skip to main content
WeightCited

Berberine pour Insulin Resistance

A

Meta-analysis of 27 RCTs found significant improvements in fasting glucose, HbA1c, and insulin sensitivity. AMPK activation is comparable to metformin. A landmark RCT (n=116) showed 500 mg 3x/day reduced body weight by 3.6 kg and triglycerides by 35.9%.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'weightcited.com'; const params = 'ingredient\u003Dberberine\u0026condition\u003Dinsulin\u002Dresistance'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

En conclusion

Meta-analysis of 27 RCTs found significant improvements in fasting glucose, HbA1c, and insulin sensitivity. AMPK activation is comparable to metformin. A landmark RCT (n=116) showed 500 mg 3x/day reduced body weight by 3.6 kg and triglycerides by 35.9%.

Key Statistics

27

Études

2500

Participants

Positive

A

Note

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Posologies couramment utilisées

general:
500 mg 2-3x/day with meals
starting:
500 mg/day and titrate
metabolicsupport:
1,000-1,500 mg/day

Limite supérieure : 1,500 mg/day; GI side effects limit intake; potential drug interactions

Moment optimal de prise : With meals (reduces GI discomfort and synchronizes with postprandial glucose metabolism)

Safety & Side Effects

Effets indésirables signalés

  • Diarrhea
  • Constipation
  • Flatulence
  • Abdominal pain
  • Potential hypoglycemia (when combined with diabetes medications)

Interactions connues

  • Diabetes medications (may potentiate — hypoglycemia risk)
  • CYP3A4 substrates (berberine is a CYP3A4 inhibitor)
  • CYP2D6 substrates
  • Cyclosporine
  • Metformin (additive effects)

Apport maximal tolérable : 1,500 mg/day; GI side effects limit intake; potential drug interactions

Consultez toujours votre professionnel de santé avant de commencer tout complément alimentaire.Consultez toujours votre professionnel de santé avant de commencer tout complément alimentaire.

Frequently Asked Questions

Does Berberine help with Insulin Resistance?
Based on 27 studies with 2,500 participants, there is strong evidence from multiple clinical trials that Berberine may support Insulin Resistance management. Our evidence grade is A (Strong Evidence).
How much Berberine should I take for Insulin Resistance?
Studies have used various dosages. A commonly studied range is 500 mg 2-3x/day with meals. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Berberine?
Reported side effects may include Diarrhea, Constipation, Flatulence, Abdominal pain. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Berberine and Insulin Resistance?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 27 peer-reviewed studies with 2,500 total participants. The overall direction of effect is positive.

Related Evidence

Avertissement FDA: Ces déclarations n'ont pas été évaluées par la Food and Drug Administration. Les produits et informations sur ce site ne sont pas destinés à diagnostiquer, traiter, guérir ou prévenir quelque maladie que ce soit. Les notes de preuve présentées sont basées sur notre analyse de la recherche publiée et évaluée par des pairs et ne constituent pas un avis médical. Consultez toujours votre professionnel de santé avant de commencer tout régime de compléments alimentaires.